Related Experiment Video
Updated: Jun 10, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
The management of gastric polyps
Andrew F Goddard1, Rawya Badreldin, D Mark Pritchard
1Digestive Diseases Centre, Royal Derby Hospital, Uttoxeter Road, Derby DE22 3NE, UK. andrew.goddard@derbyhospitals.nhs.uk
Gastric polyps require careful histological evaluation due to their malignant potential. Early detection and treatment are crucial for preventing gastric cancer and other malignancies.
Area of Science:
- Gastroenterology
- Oncology
Background:
- Gastric polyps are growths protruding into the stomach lumen, originating from the gastric epithelium or submucosa.
- Some gastric polyps, including adenomas and hyperplastic polyps, possess malignant potential.
- Untreated malignant polyps can progress to gastric cancer, highlighting the importance of histological classification.
Purpose of the Study:
- To emphasize the significance of histological type in determining the malignant potential of gastric polyps.
- To underscore the link between specific gastric polyp types and the risk of gastric cancer.
- To acknowledge the limitations in the current literature base regarding gastric polyp management.
Main Methods:
- Literature review focusing on histological classification of gastric polyps.
- Analysis of the relationship between polyp histology and malignant transformation.
- Assessment of the current evidence base for clinical recommendations.
Main Results:
- The histological type of a gastric polyp is a key determinant of its malignant potential.
- Certain polyps are precursors to early gastric cancer and may indicate broader malignancy risks.
- The existing literature provides a limited evidence base for definitive recommendations.
Conclusions:
- Accurate histological diagnosis of gastric polyps is essential for risk stratification.
- Gastric polyps with malignant potential necessitate appropriate management to prevent cancer.
- Further research is needed to strengthen the evidence base for clinical guidelines.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy